Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05749146 · ClinicalTrials.gov registry record · NA
Palliative Care for Patients With Dementia
A NA study of Dementia, sponsored by Icahn School of Medicine at Mount Sinai.
- Active
- Registry status
- NA
- Development phase
- 153
- Enrollment target
- 1
- Study location
NCT05749146: Active NA study of Dementia, sponsored by Icahn School of Medicine at Mount Sinai.
NCT05749146 is a NA study of Dementia that is active but no longer recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 153 participants, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05749146, a NA study of Dementia, is active but no longer recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
- 1
- Study location
Study Summary
A multi-site, single-blinded, parallel, randomized-controlled trial to evaluate the effectiveness of a novel model of in-home palliative care for dementia patients and their family caregivers. From inpatient and outpatient settings associated with four hospitals across New York City, patients with advanced dementia and their family caregivers will be randomized to intervention or augmented control.
Primary Outcome
This will be determined using a validated structured questionnaire administered to patient-subjects or caregiver via telephone interview or in person by the trained research coordinator. The Symptom Management at the End of Life in Dementia (SM-EOLD) scale responses range from 0 to 45 with higher scores indicating better symptom management.
Conditions Studied
Interventions
- BEHAVIORAL Home Palliative Care
Study Locations (1)
New York
- Ichan School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2023-06-08 |
| Est. Completion | 2027-03-15 |
| Phase | NA |
What the registry record for NCT05749146 still lists
NCT05749146 is an interventional study that assigns participants to a tested intervention. The registered 153 participants enrollment target is mid-sized for trials with a published cap, below the 7,722-participant average among 199 other Dementia trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which Home Palliative Care is the first listed.
NCT05749146 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05749146 about?
NCT05749146 is a clinical study titled "Palliative Care for Patients With Dementia". A multi-site, single-blinded, parallel, randomized-controlled trial to evaluate the effectiveness of a novel model of in-home palliative care for dementia patients and their family caregivers. From inpatient and outpatient settings associated with four hospitals across New York City, patients with a...
What is the current status of trial NCT05749146?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 153 participants. The study started on 2023-06-08. Estimated completion is 2027-03-15.
What conditions does trial NCT05749146 study?
This clinical trial studies the following conditions: Dementia.
What interventions are being tested in trial NCT05749146?
The interventions under investigation include: Home Palliative Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT05749146?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05749146 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05749146's enrollment target sits among peer trials
153 101st of 199 higher than 99 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Caregiver Bootcamp
RECRUITING · NA
-
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
RECRUITING · NA
-
Effect of Cognitive Empathy Training on Dementia Caregivers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05283265 · 153 participants · NA
Neurophysiological Mechanisms of Language Comprehension
- NCT05554393 · 153 participants · Phase 2
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
- NCT05584501 · 153 participants · NA
ETE Interventions in the Dental Setting
- NCT05714839 · 153 participants · Phase 1
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI